$24.14
In chiusura: Oct 13 EDT
$24.00
-0.14-0.58%
Pre-mercato: 6:56 PM EDT
Comments
Loading...
Apellis Pharmaceuticals Rapporto sugli interessi allo scoperto
APLSNASDAQ
Report sulle vendite allo scoperto
Il short interest su Apellis Pharmaceuticals Inc (NASDAQ:APLS) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 21.76M a 21.05M. Questo rappresenta il 21.95% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Apellis Pharmaceuticals Corp (XNAS:APLS) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 2.26M azioni scambiate al giorno, ci vorrebbero 9.31 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
21.05M
Vendite allo scoperto %
21.9%
Giorni di copertura
9.31
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
APLS | Apellis Pharmaceuticals, Inc. | 09/30/2025 | 10/09/2025 | 21.95% | 95,884,373 | 21,047,108 | 2,261,845 | 9.31 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/15/2025 | 09/24/2025 | 22.69% | 95,884,373 | 21,758,081 | 2,250,335 | 9.67 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/29/2025 | 09/10/2025 | 21.42% | 95,884,373 | 20,539,985 | 1,769,177 | 11.61 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | 21.14% | 95,884,373 | 20,273,707 | 2,913,900 | 6.96 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 23.04% | 95,884,373 | 22,092,024 | 3,044,053 | 7.26 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 17.31% | 95,276,723 | 16,492,598 | 1,948,010 | 8.47 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 27.45% | 95,276,723 | 26,148,815 | 1,867,422 | 14 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 26.39% | 95,276,723 | 25,140,355 | 2,268,431 | 11.08 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 26.28% | 95,276,723 | 25,034,198 | 2,513,498 | 9.96 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 28.60% | 95,276,723 | 27,245,432 | 3,360,369 | 8.11 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 30.20% | 95,276,723 | 28,771,303 | 2,263,456 | 12.71 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 28.16% | 95,276,723 | 26,833,210 | 3,081,613 | 8.71 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 24.48% | 91,955,446 | 22,511,249 | 2,165,571 | 10.4 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 21.00% | 91,955,446 | 19,313,821 | 1,465,315 | 13.18 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 22.64% | 91,955,446 | 20,815,049 | 1,738,206 | 11.98 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 19.09% | 90,832,650 | 17,341,085 | 1,439,758 | 12.04 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 18.78% | 90,832,650 | 17,055,810 | 1,473,551 | 11.57 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 19.86% | 90,832,650 | 18,039,735 | 2,522,912 | 7.15 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 24.35% | 88,205,961 | 21,477,949 | 2,152,590 | 9.98 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 22.69% | 88,205,961 | 20,011,664 | 3,061,511 | 6.54 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 24.73% | 88,205,961 | 21,811,296 | 4,485,961 | 4.86 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 26.28% | 88,205,961 | 23,182,889 | 4,450,930 | 5.21 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 23.57% | 88,205,961 | 20,786,277 | 2,084,705 | 9.97 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 23.91% | 88,205,961 | 21,088,064 | 3,827,807 | 5.51 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 17.30% | 88,205,961 | 15,260,698 | 2,289,442 | 6.67 | |
APLS | Apellis Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 17.33% | 88,205,961 | 15,284,852 | 1,397,862 | 10.93 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 18.34% | 88,205,961 | 16,173,529 | 826,033 | 19.58 | |
APLS | Apellis Pharmaceuticals, Inc. | 08/15/2024 | 08/26/2024 | 18.44% | 88,205,961 | 16,267,681 | 2,141,166 | 7.6 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 18.04% | 88,205,961 | 15,916,603 | 1,373,160 | 11.59 | |
APLS | Apellis Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 17.28% | 87,805,188 | 15,168,402 | 1,352,038 | 11.22 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 16.87% | 87,805,188 | 14,814,085 | 1,802,742 | 8.22 | |
APLS | Apellis Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 15.83% | 87,805,188 | 13,899,907 | 872,302 | 15.93 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 14.94% | 87,805,188 | 13,116,801 | 1,415,017 | 9.27 | |
APLS | Apellis Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 14.33% | 87,805,188 | 12,586,479 | 1,669,061 | 7.54 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 14.11% | 87,805,188 | 12,388,136 | 1,736,373 | 7.13 | |
APLS | Apellis Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 12.16% | 87,733,401 | 10,669,213 | 1,147,476 | 9.3 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 10.05% | 103,890,033 | 10,439,851 | 1,098,740 | 9.5 | |
APLS | Apellis Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 10.19% | 103,890,033 | 10,591,406 | 1,391,553 | 7.61 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 9.69% | 103,890,033 | 10,064,166 | 1,408,971 | 7.14 | |
APLS | Apellis Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 10.09% | 101,808,229 | 10,270,787 | 1,503,091 | 6.83 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 10.48% | 101,808,229 | 10,669,463 | 1,568,794 | 6.8 | |
APLS | Apellis Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 11.82% | 101,808,229 | 12,034,038 | 2,288,740 | 5.26 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 11.48% | 101,808,229 | 11,688,661 | 1,792,077 | 6.52 | |
APLS | Apellis Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 12.75% | 101,808,229 | 12,977,948 | 3,887,528 | 3.34 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 14.99% | 101,808,229 | 15,264,853 | 1,464,068 | 10.43 | |
APLS | Apellis Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 15.85% | 101,808,229 | 16,137,939 | 2,143,822 | 7.53 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/31/2023 | 11/09/2023 | 15.94% | 101,808,229 | 16,231,193 | 1,694,169 | 9.58 | |
APLS | Apellis Pharmaceuticals, Inc. | 10/13/2023 | 10/24/2023 | 18.40% | 101,045,573 | 18,593,076 | 2,940,235 | 6.32 |
In cerca di azioni più vendute allo scoperto?